ZP3\g=a\-EBGD60\m=.\9\m=+-\ 5\m=.\3,ZP3\g=b\-EBGD 56\m=.\4 \ m=+-\5\m=.\0, ZP3\g=a\-DG56\m=.\4 \ m=+-\ 4\m=.\0,ZP3\g=b\-DG 53\m=.\5\ m=+-\ 4\m=.\3)(means \ m=+-\ sem). Animals immunized with SIZP, ZP3 and ZP3\g=b\-EBGD showed a statistically significant reduction in the number of primary, secondary and tertiary follicles compared with controls (P < 0\m=.\01,manova), whereas animals immunized with ZP3\g=a\-EBGD, ZP3\g=a\-DGand ZP3\g=b\-DG did not (P > 0\m=.\05,manova). These results demonstrate that immunization with purified ZP3\g=a\macromolecules (ZP3\g=a\-EBGD,ZP3\g=a\-DG) or ZP3\g=b\-DG does not produce histopathological changes in ovaries. Such deglycosylated ZP macromolecules represent potential target antigens for immunocontraceptive development.
Introduction
The zona pellucida is a noncellular layer that surrounds the mammalian oocyte and preimplantation embryo. Numerous investigations among various species have revealed that it is composed of three to four developmentally regulated glycoproteins that serve essential functions during fertilization and early development (Dunbar et al., 1981; Sacco et al., 1981; Hedrick &Wardrip, 1987; Yurewicz et al., 1987; Wassarman, 1988) , such as species-specific attachment and binding of spermatozoa (Hanada & Chang, 1972; O'Rand, 1988) , induction of the acrosome reaction (Bleil & Wassarman, 1983; Cherr et al., 1986) and the block to polyspermy (Braden et al., 1954) .
Biological and immunological studies indicate that the zona is a potent heteroimmunogen: zonae from different species share common antigenic determinants and zona antisera possess contraceptive activity in vitro and in vivo (Sacco, 1981; Dunbar, 1983; Maresh & Dunbar, 1987;  'Correspondence to Dr Gary R. Jones, 4483 Sweet Shrub Court, Concord, CA 94521. Henderson et ai, 1988) . Human and porcine zonae share common antigens (Sacco, 1977; Koyama et ai, 1985) and antiserum to porcine zonae demonstrates contraceptive efficacy in humans (Trounson et al., 1980; Henderson et ai, 1987a) . Consequently, the porcine zona has gained considerable attention as a potential immunocontraceptive target antigen for possible develop¬ ment of a human contraceptive vaccine (Yurewicz et ai, 1986; Sacco, 1987; Sacco et ai, 1990; Sacco et ai, 1991) .
Porcine zona-based immunocontraception has been shown to be exceptionally effective in inhibiting fertility in many species. Its mechanism of action has been presumed to be antibody disruption of sperm-egg interaction at the level of the zona. However, recent studies in vivo in several species including primates revealed that immunization with porcine zona material may also inhibit fertility at the level of the ovary by disrupting folliculogenesis (Sacco et al., 1983; Skinner et ai, 1984; Mahi-Brown et ai, 1985; Henderson et ai, 1988; Upadhyay et ai, 1989) . This method of inhibiting fertility by zona antibodies is obviously not suitable for use in humans. Recent studies of zona-based immunocontraception have therefore concentrated on approaches directed towards obviating disruptive effects on normal ovarian function after immunization with zona material.
One approach is to consider selection of appropriate porcine zona immunogens for immunization. Such immunogen candidates include: (i) an isolated and highly purified glycoprotein family; (ii) a deglycosylated or partially deglycosylated preparation of such a glycoprotein family; (iii) a proteolytic fragment or synthetic peptide from a specific zona glycoprotein; or (iv) a specific genetically engineered zona epitope product. A recent study performed in rabbits using specific partially deglycosylated and deglycosylated porcine zona components as immunogens clearly indicated that high-titred zona antisera could be raised without disturbance of ovarian hormones (Keenan et ai, 1991) . The aim of the present study was to evaluate, histologically, ovaries from immunized rabbits. Our results revealed that rabbits immunized with some of these deglycosylated zona fractions also showed no disruption of follicular development compared with controls. Coupled with the earlier endocrinological data from this species, it is concluded that immunization with certain porcine zona fractions does not produce adverse effects on the ovary. These data thus encourage continued investigation of such components for immunocontraceptive purposes.
Materials and Methods
Antigen preparation SIZP. Heat-solubilized isolated zonae pellucida (SIZP) were obtained as described by Yurewicz et al (1983, 1987 (Henderson et al, 1979) and the ZP3 renatured by dialysis against 6 mol guanidine hydrochloride 1_1 (McCoy & Wong, 1981 Forty-eight female, sexually mature, Dutch-belted rabbits, 6 months of age, were assigned to one of the following groups: group I: SIZP (n = 6); group II: ZP3 (n = 6); group III: ZP3a-EBGD (n = 6); group IV: ZP3ß-EBGD ( = 6); group V: ZP3a-DG (n = 6); group VI; ZP3ß-DG ( = 6); group VII: Freund's complete adjuvant alone (n = 6); group VIII: 015 mol saline 1" ' (n = 6). Groups I-VI were designated as treatment groups and groups VII and VIII as control groups.
Each animal in the treatment groups was injected with a total of 120 pg of antigen as follows: half (60 pg) of the total dose was divided equally in a series for three injections once a week. The remaining antigen (60 pg) was adminis¬ tered as a single booster dose once peak antibody titres to ZP3 were obtained as determined by radioimmunoassay .
For injections, antigens were solubilized in 01 mol phosphate-buffered saline (pH 7-2) 1 (PBS) and emulsified immediately before use in an equal volume of Freund's complete adjuvant. Total volume per injection was 10 ml. Immunizations were performed using a multisite intradermal injection regimen. Freund's complete adjuvant was used for the first injection and Freund's incomplete adjuvant for all subsequent injections including the booster. Control groups were injected in a similar way with either equal volumes of Freund's adjuvant and PBS, or with saline alone using the same injection technique and schedule.
Serum collection
Blood was obtained from the marginal ear vein each week (5 ml) starting 1 week after initial immunization and continuing until 1 month after administration of the booster. Blood was then obtained once a month for the remainder of the study. Serum was collected and stored at -20°C until assayed for antibody titres and serum oestradiol levels.
Radioimmunoassay
Antibody response to the various zona subfractions was measured by a double antibody radioimmunoassay following procedures previously described for the zona system Sacco et al, 1983 ).
[125I]-labelled ZP3 was used as tracer and all sera assayed for titre determination were diluted 1:1000 before use.
Details of assay validation for sensitivity, precision, accuracy, specificity and other parameters have been described by Subramanian et al (1981 
Results

Antibody titres
After the initial immunization series of three injections, and booster administration at 15 weeks, antibody titres rose rapidly and peaked at 18 weeks after initial immunization at the 50-70% binding level depending upon the particular immunogen injected (Fig. 2) .
Titration profiles for all antigen groups were similar but antibody titres varied depending upon antigen used. A direct relationship was observed between immunogenicity and carbohydrate content of the immunogen. Fully glycosylated SIZP and ZP3 showed the highest binding (71-9% ± 1-2% and 700% ± 2-5%, respectively) while ZP3a-DG and ZP3ß-DG showed the lowest (56-4% + 40% and 53-5% ± 4-3%, respectively) (mean + sem). A significant decrease in binding (P = < 0-01) was noted for all groups between the peak binding observed at approxi¬ mately 18 weeks and at 38 weeks after immunization, the point at which the study was terminated. No zona antibody activity was detected in animals in either of the control groups (groups VII and VIII) or in the pre-immunization control blood samples from all rabbits.
Histology
No statistical differences in follicular development were observed in ovaries obtained from rabbits in the saline or adjuvant control groups. Data from these control groups were therefore pooled for comparison with treatment groups.
In general, a direct correlation was found between degree of ovarian histopathology observed and carbohydrate content of the immunogen injected. Ovaries from SIZP-and ZP3-immunized rabbits showed the earliest and greatest follicular growth disruption compared with the controls. In these two groups, disturbances in follicular development were observed as early as 6 and 12 weeks after initial immunization with SIZP and ZP3, respectively (Fig. 3a,b) . SIZP-and ZP3-immunized animals showed significantly fewer (P < 0-01) primary, secondary and tertiary follicles compared with controls (Fig. 4) and continued to show this marked disruption of follicular development throughout the course of the study (Fig. 3c,d) Ovaries from ZP3ß-EBGD-immunized rabbits showed an obvious reduction in all stages of follicle development (Fig. 5b ) first observed at 24 weeks after immunization (Fig. 6a) . Ovaries from rabbits immunized with ZP3ß-DG showed a significant decrease in primary follicles, apparent initially at approximately 18 weeks after immunization. Secondary and tertiary follicular develop¬ ment in this group did not differ significantly from the controls over the 36 weeks after immunization (Fig. 7b) . In addition, oocytes and their surrounding zona pellucida appeared intact with no discernible disruptions (Fig. 6d) .
ZP3a-EBGD-and ZP3a-DG-immunized rabbits, in contrast, showed normal follicular develop¬ ment (Fig. 6b,c) and no statistically significant reduction in tertiary, secondary or primary follicular development compared with controls for the duration of the study (Figs 5a and 7a) . Furthermore, repeated histological evaluation failed to reveal any evidence of cortical thinning, perifollicular fibrosis, stromal cell hyperplasia, leucocytic infiltration or zona pellucida disruption for both ZP3a-EBGD-and ZP3a-DG-, as well as for ZP3ß-DG-immunized animals ( In an attempt to identify such a zona immunogen, we compared ovarian histological findings from rabbits immunized with a number of glycosylated and deglycosylated porcine zona compo¬ nents. Rabbits were chosen since they appear to be particularly sensitive to zona-antibody-induced disruptions of normal ovarian cyclicity arid folliculogenesis (Skinner et ai, 1984; Sehgal et al., 1989) . A zona immunogen that does not produce ovarian histopathology in rabbits would be an excellent prospective target antigen for additional immunocontraceptive studies in more appropriate species such as nonhuman primates. This study is also the first in which such a panel of zona immunogens was examined for this purpose in a single species. pooled data from six animals over the duration of the study.
Immunization with the glycosylated zona components, SIZP and ZP3, resulted in severe disruptions to normal ovarian histology which were detected 6 to 12 weeks after immunization with SIZP and ZP3, respectively. Ovaries from these animals were characterized by drastic reductions, or alteration, or by both, of all follicular stages. These findings are thus similar to other investi¬ gations which used total zona proteins (i.e. SIZP) for immunization of either rabbits (Skinner et ai, 1984; Sehgal et ai, 1989) or other species (Gulyas et ai, 1983; Mahi-Brown et ai, 1988) . The ovarian histological disruptions observed in this study after immunization of rabbits with ZP3 were also similar to results obtained in species such as dogs (Mahi-Brown et ai, 1988), squirrel monkeys (Sacco et ai, 1987 (Sacco et ai, , 1990 (Sacco et ai, , 1991 , bonnet monkeys (Upadhyay et ai, 1989) and baboons (Dunbar et ai, 1989 (Sacco et ai, 1989a) .
These histological findings concur with a recent endocrinological study in rabbits, which used the same zona immunogens (Keenan et ai, 1991) . In this study, animals immunized with SIZP, ZP3 and ZP3ß-EBGD showed significant perturbation of luteinizing hormone, follicle-stimulating hormone and progesterone levels, whereas animals immunized with ZP3a-EBGD, ZP3a-DG and ZP3ß-DG displayed no significant disruptions in normal hormone profiles. Coupled with our histological findings, these data indicate that immunization with ZP3a-EBGD and ZP3a-DG does not disrupt normal ovarian function in the rabbit, in spite of the presence of high-titred zona antisera directed against these components. These findings encourage the continued investiga¬ tion of partially deglycosylated and deglycosylated zona components for immunocontraceptive purposes. They are also of particular relevance to those studies directed towards engineered contraceptive vaccines based upon synthetic or recombinant peptide molecules.
Whereas carbohydrate has been demonstrated to play a significant role in the immunogenicity and antigenicity of the porcine zona ZP3 molecule (Sacco et ai, 1986) , high-titred zona anti¬ sera that possess contraceptive activity can be produced against enzymatically and chemically deglycosylated zona components (Henderson et ai, 1987a, b; Sacco et ai, 1989a; Aitken et ai, 1990) . Contraceptive zona antibodies are also elicited when synthetic zona peptides (Millar et ai, 1989; Sacco et ai, 1989b) Current findings indicate that, whereas significantly high titres (>53-5% binding by radio¬ immunoassay in this study) can be produced against deglycosylated zona immunogens, such titres typically are lower than those produced against the corresponding glycosylated form. It is unclear whether the lack of histopathological effects on ovaries observed in this study with use of deglycosylated zona components can be attributed to these lower titres or to qualitative differences in the antibodies themselves which are developed against the glycosylated or deglycosylated components. Data from the present investigation support the latter suggestion. For example, quantitatively similar titres were obtained using ZP3ct-EBGD and ZP3ß-EBGD. Yet, immunization with ZP3a-EBGD had no effect on ovarian histology while immunization with ZP3ß-EBGD did result in significant reductions of primary, secondary and tertiary follicles. These results suggest that the qualitative nature of the antibodies induced after immunization with such zona compo¬ nents may be more significant than the absolute titre obtained. Obviously, additional studies must be performed to clarify this issue. In summary, immunization of rabbits with ZP3a-EBGD and ZP3a-DG elicits high-titred zona antisera that have no adverse effects on normal ovarian histology. Earlier findings (Keenan et ai, 1991) have indicated that immunization with these components also does not disrupt ovarian cyclicity and endocrine profiles. ZP3a-EBGD and ZP3ct-DG are therefore primary immunocontraceptive target antigens for future investigation.
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